Usana Health Sciences (USNA) Total Non-Current Liabilities (2011 - 2026)

Usana Health Sciences (USNA) has reported Total Non-Current Liabilities for 16 consecutive years, with $110.3 million the latest figure, recorded in Q3 2026.

• On a quarterly basis, Total Non-Current Liabilities fell 12.63% year-over-year to $110.3 million in Q3 2026; TTM through Jul 2026 was $110.3 million, a 12.63% decrease from a year earlier, with the FY2026 full-year figure at $133.5 million, down 7.13% from the prior year.
• Total Non-Current Liabilities was $110.3 million for Q3 2026 at Usana Health Sciences, down from $122.3 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $169.4 million in Q2 2022 and troughed at $108.5 million in Q2 2024.
• A 5-year average of $131.4 million and a median of $126.3 million in 2025 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities retreated 21.2% in 2022 and grew 20.76% in 2025, its largest moves.
• Over 5 years, Total Non-Current Liabilities stood at $147.9 million in 2022, then declined by 16.57% to $123.4 million in 2023, then gained by 16.45% to $143.7 million in 2024, then declined by 14.31% to $123.1 million in 2025, then declined by 10.39% to $110.3 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $110.3 million (Q3 2026), $122.3 million (Q2 2026), and $133.5 million (Q1 2026), per Business Quant data.